Inventor
TUTTLE RONALD R
US30 patents
⚠️ This page may combine multiple inventors who share the name “TUTTLE RONALD R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TREGA BIOSCIENCES INC
7 patentsUS5786332AJul 28, 1998
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
TREGA BIOSCIENCES INC51 citations95
US5760001AJun 2, 1998
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
TREGA BIOSCIENCES INC52 citations95
US5726156AMar 10, 1998
Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
TREGA BIOSCIENCES INC59 citations93
US6245738B1Jun 12, 2001
Cytokine restraining agents
TREGA BIOSCIENCES INC21 citations92
US5888969AMar 30, 1999
Use of cytokine restraining agents to treat inflammatory bowel disease
TREGA BIOSCIENCES INC11 citations73
US5741774AApr 21, 1998
Use of a cytokine regulatory agent to treat rheumatoid arthritis
TREGA BIOSCIENCES INC4 citations62
US5888978AMar 30, 1999
Method for reducing the severity of gastro-intestinal damage
TREGA BIOSCIENCES INC1 citations49
KEY PHARMA
6 patentsUS4425336AJan 10, 1984
3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes
KEY PHARMA19 citations82
US4424209AJan 3, 1984
3,4-Di-isobutyryloxy-N- 3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl!-beta-phenethylamine cyclodextrin complexes
KEY PHARMA21 citations82
US4562206ADec 31, 1985
Orally effective inotropic compounds
KEY PHARMA7 citations74
US4511570AApr 16, 1985
Senile dementia treatment
KEY PHARMA13 citations74
US4454142AJun 12, 1984
Hyperkinetic child treatment agent
KEY PHARMA11 citations74
US4483860ANov 20, 1984
Hyperkinetic child treatment agent
KEY PHARMA2 citations63
GENSIA PHARMA
5 patentsUS5658889AAug 19, 1997
Method and compounds for aica riboside delivery and for lowering blood glucose
GENSIA PHARMA109 citations96
US5286252AFeb 15, 1994
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GENSIA PHARMA110 citations96
US5108363AApr 28, 1992
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GENSIA PHARMA75 citations95
US5234404AAug 10, 1993
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GENSIA PHARMA63 citations94
US5395970AMar 7, 1995
1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol
GENSIA PHARMA5 citations71